Nephrotic syndrome after treatment with pamidronate
Authors:
- Paul L. FinePFPaul L. Fine
- Vivette D. D'AgatiVDVivette D. D'Agati
- 1 May 2002
- journal article
- case report
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 39 (5) , 1118-1122
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopathological and follow-up studyKidney International, 1999
- The Dysregulated Podocyte PhenotypeJournal of the American Society of Nephrology, 1999
- Comparative Tolerability of Drug Therapies for Hypercalcaemia of MalignancyDrug Safety, 1999
- Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.Journal of Clinical Oncology, 1998
- Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.Journal of Clinical Oncology, 1998
- Renal Tolerability Profile of Novel, Potent Bisphosphonates in Two Short‐Term Rat ModelsBasic & Clinical Pharmacology & Toxicology, 1997
- Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic studyKidney International, 1996
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaNew England Journal of Medicine, 1996
- Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosisKidney International, 1994
- Pathology of HIV-associated nephropathy: A detailed morphologic and comparative studyKidney International, 1989